By Marissa Bergman and Annabelle Santos Volgman, MD
Heart disease long was thought to be solely a men’s health concern, but it’s the No. 1 killer of women as well. In fact, 2013 was the first year since 1984 that fewer women died of heart disease than men. This decline was the result of the tireless work of a small group of women who have dedicated their lives to eradicating the misunderstanding and unequal treatment of women’s heart disease. Since March is Women’s History Month, it’s an apt time to look back on their lifesaving work.
Heart disease first came to medical prominence in 1948 with the start of the long-term, ongoing Framingham Heart Study — which now is in its third generation of subjects residing in the Massachusetts town for which the study is named. It was reported in 1955 that age and sex were clearly risk factors for heart attacks; men suffered from heart attacks as early as their thirties and forties, while women seemingly were spared, because they had much less incidence and experienced heart attacks about ten years later than men.
By 1979, 30,000 more men were succumbing to heart disease than women, cementing the perception of heart disease as a men’s disease. As a result, medical attention was focused almost exclusively on men and their hearts — the Multiple Risk Factor Intervention Trial started in 1974 only examined one sex.
By Helen J. Burgess, PhD, and John W. Burns, PhD
Can light therapy help people with chronic pain? We conducted a study to find the answer. You may wonder why such a possibility occurred to us.
We already know that light treatment — particularly light treatment in the morning — can reduce depression. This effect appears due to special non-visual receptors in the eye that transmit light straight to the amygdala, a key mood center in the brain.
We also know that when you improve mood, you can decrease or diminish pain, and improve people’s ability to cope and function with pain. On the other hand, medications often prescribed for chronic pain, including antidepressants and antiseizure medications, can have only small effects on pain, and that the side effects are significant enough that many people stop taking them. Finally, we know that opioid medications carry many risks, and patients are looking for affordable non-drug treatments that they can use in their own homes.
Ten women tested
With these considerations in mind, we ran a pilot study to test if light treatment could help people in chronic pain. We enrolled 10 women with fibromyalgia — a condition characterized by chronic widespread pain — into a two-week study. For the first week, the women slept at home as per usual. Then we brought them into the Rush Sleep Disorders Service and Research Center and asked them to report on their baseline function by completing the Fibromyalgia Impact Questionnaire. This assessment asks about daily tasks such as how hard it is to walk several blocks, climb stairs and drive a car.
By Leslie A. Deane, MD
Bladder cancer can be a devastating diagnosis, especially when the deep muscle of the bladder is involved. It affects approximately 76,000 people in the United States annually, with 18,000 deaths. Men are affected three times as often as women.
The treatments for this condition are life-changing, to say the least, and the goal of surgeons treating patients is to minimize the morbidity and hasten recovery, attempting to normalize quality of life thereafter.
Robotic surgery has changed the approach to patients with this disease, allowing duplication of open techniques, albeit with a less invasive alternative. We have been able to remove the bladder, remove the lymph nodes and reconstruct the bladder using the small intestine, all inside the body (intracorporeal).
By Fernando De Maio, PhD, Patricia O’Campo, PhD, David Ansell, MD, MPH, and Raj C. Shah, MD
Health inequities — differences that are avoidable, unnecessary and unjust — are a striking feature of cities in the United States, including Chicago. While it is true that all of our city’s 77 communities have experienced an improvement in some key health indicators over the past three decades, inequities between communities have grown over this time.
New research from the Center for Community Health Equity — a collaboration of Rush University Medical Center and DePaul University — explores the prevalence of low birth weight deliveries in Chicago communities. (Our study defined this prevalence as the percentage of live births at less than 2,500 grams, or roughly 5.5 pounds.) This statistic is an important indicator of population health and is widely used to study the health effects of racism.
Good health, as we have seen again and again, is a product of social justice, and Chicago’s deep-rooted racial/ethnic segregation harms the health of its residents. Across Chicago communities, the proportion of low birth weight is 10 percent, with the best-off communities near 3 percent and the worst-off communities approaching 20 percent. Segregation plays an important role in explaining these differences: The most highly segregated African-American communities, among them Avalon Park and Washington Heights, have the most prevalent low birth weight rates. Accounting for 70 percent of the differences between communities are segregation, unemployment and low educational attainment, which are factors that all highly correlated with low birth weight.
By Kyran Quinlan, MD, MPH
When he was 3 years old, Zamari was at home, waiting for his soup being heated in the microwave. His mother was home with him, but involved in a conversation. Zamari could tell that the microwave had finished cooking and it was time to eat. He couldn’t wait. He left where he was with his mother and went into the kitchen. He opened the door of the microwave and removed the bowl of soup from it, and as he did, it spilled on him. On his chest. Scalding hot soup on his chest.
And he screamed. He says it felt like someone had put a torch on him.
His mother heard his cries and came running. She took his shirt off and pulled his burned, peeling chest skin off with it. He was brought to the hospital and was admitted to the burn unit for care of his wound. He was in tremendous pain. His wound required dressing changes in the operating room. The hospital stay lasted a week and left him with a permanent large scar on his chest.
Jorge O. Galante, MD, MDSc, a trailblazing orthopedic surgeon, inventor and professor who revolutionized the science of joint replacement, died on Feb. 9 on Sanibel Island, Florida. He was 82.
At the time of his death, Galante was a life trustee and the Grainger Director Emeritus of the Rush Arthritis and Orthopedic Institute at Rush University Medical Center in Chicago.
Galante joined Rush, previously known as Presbyterian-St Luke’s, in 1972 as the first chairperson of its newly established Department of Orthopedic Surgery, a position he held until 1994. Over the years, he made Rush home to one of the country’s leading orthopedic programs. U.S. News & World Report currently ranks it as the country’s fourth best orthopedic program in the United States and the No. 1 program in Illinois.
An exceptionally talented surgeon himself, Galante nurtured generations of orthopedic surgeons and scientists at Rush, many of whom still practice today. He also established the Rush’s Motion Analysis Lab, which studies the functional performance of people during activities of daily living in order to improve the physical capabilities of people suffering from musculoskeletal ailments.
By Susan Frick
At our last Without Warning meeting, Bob, whose wife passed away from younger-onset Alzheimer’s disease several years ago, told me something interesting. He realized that during the 10 years he has been attending Without Warning meetings, he has learned how to share his story. While sharing your story might seem like a small task, I’ve grown to realize that it is a profound and healing skill.
Without Warning, a 13-year-old support program of the Rush Alzheimer’s Disease Center, is for families living with younger-onset Alzheimer’s disease. Younger-onset Alzheimer’s means the person is diagnosed by the age of 65 or younger. This is a young age to be experiencing Alzheimer’s disease. Group members might still be working, raising children, driving and have friends who aren’t experiencing such a life-changing disease. Alzheimer’s at any age can make someone feel isolated and different, but these feelings only intensify when someone is young.
‘Agony of an untold story’
The author and poet, Maya Angelo once said, “There is no greater agony than bearing an untold story inside you.” As a group facilitator, I have seen the agony of an untold story in both the person with Alzheimer’s and their family members, and there are numerous reasons their stories are not heard or told.